Chapter 3 Market Dynamics
- Market Drivers
- Rising R&D Investment
- Growth in Outsourcing of Non-Core Function
- Cros Add Efficiency
- Market Restraints
- Challenges in Preclinical Research Outsourcing
- Lack of Skilled Professionals
- Market Opportunities
- Growing Opportunities in Asia-Pacific
- Inorganic Strategies
- Emerging Markets
Chapter 4 Impact of Covid-19
- Overview of Covid-19 Crisis
- Impact of Covid-19 on the Cro Market
- Current Outlook
Chapter 5 Global Market Overview
- Preclinical Process Overview
- Market for Drug Substance/Active Pharmaceutical Ingredient Manufacturing for Drug Development
- Manufacturers
- Market Estimate for Outsourcing Api Manufacturing for Drug Development
- Formulation and Dosage Design Outsourcing Services
- Companies
- Market Overview and Estimates for Outsourcing of Formulation Development
- Analytical/Bioanalytical Methods Development, Validation and Testing
- Analytical Methods Development
- Analytical Methods Validation, Verification and Qualification
- Analytical Testing Method Development and Validation Market Landscape and Estimates
- Companies/Providers
- Metabolism, Pharmacokinetics and Toxicology Outsourcing
- Companies/Providers
- Market Estimates: Metabolism, Pharmacokinetics and Toxicology Outsourcing Services
- Preclinical Stage Outsourcing Services
- Cros and Preclinical Research Outsourcing
- Contract Manufacturing
- Contract Research
Chapter 6 Regulatory Landscape
- Fda Regulation and Impact
- Regulations on Sponsor Activities
- The Declaration of Helsinki
- Cdisc Standards
- Regulations for Contract Manufacturing Services
- Regulations for Contract Pharmaceutical Clinical Research in Each Stage of Drug Discovery and Development Process
- Current Market Trends
- Existing Drugs for New Indications
- Increased Competition
Chapter 7 Market Analysis by Functional Service
- Discovery Services
- Chemistry
- Bioanalysis
- Toxicology
Chapter 8 Market Analysis by Region
- Overview
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- South America
- Middle East & Africa
Chapter 9 Competitive Landscape
- Market Share Analysis
- Current Pharma/Cro Contracts
- Mergers and Acquisitions
Chapter 10 Analysis of Market Opportunities
- Porter's Five Forces Analysis
- Threat of New Entrants
- Threat of Substitutes
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Competitive Rivalry/Degree of Competition
- Swot Analysis
- Strengths of the Global Market for Preclinical Research Outsourcing Services
- Challenges Within the Global Market for Preclinical Research Outsourcing Services
- Opportunities in the Global Market for Preclinical Research Outsourcing Services
- Threats to the Global Market for Preclinical Research Outsourcing Services
Chapter 11 Company Profiles
- Top 11 Cros
- Charles River Laboratories
- Eurofins Scientific
- Evotec
- Frontage Labs
- Icon plc
- Iqvia
- Laboratory Corporation of America Holdings
- Medpace
- Sgs Sa
- Thermo Fisher Scientific Inc.
- Wuxi Apptec
List of Tables
Summary Table: Global Market for Preclinical Research Outsourcing Services, by Preclinical Services, Through 2026
Table 1: R&D Investment, by Major Companies, 2019-2020
Table 2: Leading CROs in India
Table 3: Companies in the API Manufacturing Sector/Average Annual Revenues
Table 4: Companies Providing Formulation and Dosage Design Services for Drug Development (Examples)
Table 5: Distribution of Company Shares of the CDMO Sector by Revenue Range
Table 6: Companies Providing Analytical Testing Method Development and Validation Services for Drug Development (Examples)
Table 7: Companies Providing Drug Metabolism and Toxicology Services for Preclinical Drug Development (Examples)
Table 8: New Drug Approvals in the Global Biopharmaceuticals Market, 2006-2021
Table 9: Approved Drugs Repurposed for Infectious Diseases
Table 10: Global Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 11: Global Market for Discovery Services, by Region, Through 2026
Table 12: Global Market for Chemistry Services, by Region, Through 2026
Table 13: Global Market for Bioanalysis Services, by Region, Through 2026
Table 14: Global Market for Toxicology Services, by Region, Through 2026
Table 15: Global Market for Preclinical Research Outsourcing Services, by Region, Through 2026
Table 16: North American Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 17: European Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 18: Asia-Pacific Clinical Trial Regulatory Bodies
Table 19: Asia-Pacific Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 20: RoW Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 21: Pharma and CRO Partnership Alliances for Preclinical Research Services
Table 22: Recent M&As in CROs and Pharma Outsourcing Sector, 2016-2021
Table 23: Porter’s Five Forces Analysis
Table 24: Service Offerings, Major CROs
Table 25: Charles River Laboratories: Revenues, 2018-2020
Table 26: Eurofins Scientific: Revenue, 2018-2020
Table 27: Evotec: Revenues, 2018-2020
Table 28: Frontage Labs: Revenue, 2018-2020
Table 29: ICON plc: Revenue, 2018-2020
Table 30: IQVIA: Revenues, 2018-2020
Table 31: LabCorp: Revenue, 2018-2020
Table 32: Medpace: Revenues, 2018-2020
Table 33: SGS SA: Revenue, 2018-2020
Table 34: Thermo Fisher Scientific Inc.: Revenue, 2018-2020
Table 35: WuXi AppTec: Revenue, 2018-2020
Table 36: Abbreviations and Acronyms
List of Figures
Summary Figure: Global Market for Preclinical Research Outsourcing Services, by Preclinical Services, 2020–2026
Figure 1: Drug Approval Timeline
Figure 2: FDA cGMP Manufacturing Guidance Documents
Figure 3: FDA Site Inspections
Figure 4: European cGMP Guideline Documentation
Figure 5: European Site Inspection Outcomes
Figure 6: Global Market Size and Growth of Preclinical Research Outsourcing Services, 2019-2026
Figure 7: Pharma R&D Spending, 2016-2026
Figure 8: Global Prescription Drug Sales, 2016-2026
Figure 9: Global Market Shares of Preclinical Research Outsourcing Services, by Functional Service, 2020
Figure 10: Global Market for Discovery Services, 2019-2026
Figure 11: Global Market for Discovery Services, by Region, 2019-2026
Figure 12: Global Market for Chemistry Services, 2019-2026
Figure 13: Global Market for Bioanalysis Services, 2019-2026
Figure 14: Global Market for Bioanalysis Services, by Region, 2019-2026
Figure 15: Global Market for Toxicology Services, 2019-2026
Figure 16: Global Market for Toxicology Services, by Region, 2019-2026
Figure 17: Global Market for Preclinical Research Outsourcing Services, by Region, 2020–2026
Figure 18: Global Market Shares of Preclinical Research Outsourcing Services, by Region, 2020
Figure 19: North American Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 20: European Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 21: Asia-Pacific Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 22: Asia-Pacific Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 23: Global Market Shares of Leading Preclinical Research Outsourcing Service Providers, 2020
Figure 24: Expanding Value, Outsourcing Deals Involving CROs, 2007-2017
Figure 25: SWOT Analysis of the DTC Testing Market
Figure 26: Charles River Laboratories: Revenue Share, by Segment, 2020
Figure 27: Eurofins Scientific: Revenue Share, by Segment, 2020
Figure 28: Evotec: Revenue Share, by Segment, 2020
Figure 29: Frontage Labs: Revenue Share, by Segment, 2020
Figure 30: IQVIA: Revenue Share, by Segment, 2020
Figure 31: LabCorp: Revenue Share, by Segment, 2020
Figure 32: SGS SA: Revenue Share, by Segment, 2020
Figure 33: Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2020
Figure 34: WuXi AppTec: Revenue Share, by Segment, 2020
